The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMedicx Fund Regulatory News (MXF)

  • There is currently no data for MXF

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - MedicX Fund Limited

1 Mar 2019 13:10

RNS Number : 6276R
Royal Bank of Scotland Group PLC
01 March 2019
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

The Royal Bank of Scotland Group plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

Adam & Company Investment Management Limited

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

MedicX Fund Limited

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

N/A

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

28 February 2019

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

YES / NO / N/A

If YES, specify which:

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

6,554,153

 

1.48

0

0.00

(2) Cash-settled derivatives:

 

0

0

0

0.00

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0

0

0.00

 

TOTAL:

6,554,153

 

1.48

0

0.00

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

Ordinary

Sale

 

3,500

£0.926

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

YES/NO

 

 

Date of disclosure:

01 March 2019

Contact name:

Suzanne Davidson

Telephone number*:

0131 626 4120

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

LEI: 2138005O9XJIJN4JPN90

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RETUGUUUWUPBGWG
Date   Source Headline
9th Feb 201212:06 pmRNSCompletion of new debt facility
30th Jan 20125:38 pmRNSProspectus Published
26th Jan 201211:40 amRNSAGM and Annual Report
25th Jan 20121:48 pmRNSNotice of dividend
19th Jan 201211:35 amRNSNotification of major interest in shares
3rd Jan 201211:22 amRNSTotal voting rights
3rd Jan 201211:19 amRNSAllotment of shares to investment adviser
3rd Jan 201211:14 amRNSAllotment of shares to directors
22nd Dec 20112:15 pmRNSIssue of new ordinary shares
22nd Dec 20111:48 pmRNSAcquisition of new primary care medical centre
21st Dec 20115:51 pmRNSAcquisition of new primary care medical centre
14th Dec 20112:52 pmRNSAdditional Listing
8th Dec 20117:01 amRNSProposed dividend for year ended 30 September 2012
8th Dec 20117:01 amRNSAmendment to Investment Adviser fee structure
8th Dec 20117:00 amRNSResults for the year ended 30 September 2011
23rd Nov 20112:59 pmRNSScrip Calculation Price
22nd Nov 20115:43 pmRNSScrip Dividend Circular
15th Nov 20115:24 pmRNSBlock listing six monthly return
10th Nov 20114:49 pmRNSQuarterly NAV and Dividend Announcement
7th Nov 20115:36 pmRNSTransfer of shares held by Director
3rd Oct 20117:00 amRNSAllocation to Directors
3rd Oct 20117:00 amRNSTotal Voting Rights
3rd Oct 20117:00 amRNSAllocation to Investment Adviser
29th Sep 20118:53 amRNSAdditional Listing
27th Sep 20112:00 pmRNSAcquisition of new primary care medical centre
24th Aug 20114:28 pmRNSScrip Calculation Price
23rd Aug 20113:31 pmRNSCircular to Shareholders - Scrip Dividend Scheme
10th Aug 201112:10 pmRNSAcquisition of new primary care medical centre
10th Aug 201112:06 pmRNSAcquisition of new primary care medical centre
5th Aug 20118:44 amRNSInterim Management Statement
2nd Aug 20119:29 amRNSNotice of dividend
1st Aug 20115:00 pmRNSTotal Voting Rights
26th Jul 20117:00 amRNSAcquisition
7th Jul 20119:23 amRNSIssue of new ordinary shares
4th Jul 20119:08 amRNSTotal Voting Rights
4th Jul 20119:06 amRNSAllotment of scrip shares to Investment Adviser
4th Jul 20119:03 amRNSAllotment of scrip shares to Directors
28th Jun 20114:42 pmRNSAdditional Listing
20th Jun 20112:26 pmRNSTotal voting rights
20th Jun 20112:23 pmRNSIssue of new ordinary shares
20th Jun 20112:20 pmRNSRochdale Acquisition
26th May 20117:00 amRNSResults for the six months to 31 March 2011
25th May 20114:56 pmRNSScrip Calculation Price
24th May 20115:06 pmRNSCircular to Shareholders - Scrip Dividend Scheme
24th May 201112:10 pmRNSNotification of Major Interest in Shares
12th May 20114:13 pmRNSBlock listing six monthly return
12th May 20114:12 pmRNSQuarterly Net Asset Value
4th May 20115:07 pmRNSNotice of dividend
4th Apr 20112:53 pmRNSNotification of Major Interest in Shares
1st Apr 20111:53 pmRNSTotal voting rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.